Skip to main content

4 Result(s)

within Sakkaraiappan Ramalingam Remove this filter

and

  1. No Access

    Article

    Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies

    Capecitabine in combination with docetaxel given every 3 weeks has shown a high degree of activity in a number of tumor types, but at the expense of significant toxicity. To improve the therapeutic index, we e...

    Ramesh K. Ramanathan, Sakkaraiappan Ramalingam… in Cancer Chemotherapy and Pharmacology (2005)

  2. No Access

    Article

    Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study

    To evaluate the efficacy of carboplatin and docetaxel combination in patients with advanced non-small-cell lung cancer.

    Sakkaraiappan Ramalingam, Tracy W. Dobbs… in Cancer Chemotherapy and Pharmacology (2004)

  3. No Access

    Article

    Docetaxel plus cisplatin in non-small-cell lung cancer

    Chandra Belani, Sakkaraiappan Ramalingam… in Drugs & Therapy Perspectives (2004)

  4. No Access

    Article

    Docetaxel Plus Cisplatin

    Chandra Belani, Sakkaraiappan Ramalingam in American Journal of Cancer (2003)